The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.00
Bid: 35.50
Ask: 36.50
Change: 0.00 (0.00%)
Spread: 1.00 (2.817%)
Open: 36.00
High: 35.50
Low: 35.50
Prev. Close: 36.00
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

1 Aug 2018 13:24

RNS Number : 5083W
Creo Medical Group PLC
01 August 2018
 

1 August 2018

Creo Medical Group plc

("Creo" or the "Company")

 

Result of General Meeting

 

Creo Medical Group plc (AIM: CREO) is pleased to announce that, at the General Meeting held today, all resolutions were duly passed by means of a poll vote. The total number of votes received for each resolution is set out below:

 

Resolution No.

Votes for

Votes against

Votes total

Votes withheld

01

63,639,528 (94.09%)

 

3,995,278 (5.91%)

67,634,806 (83.37%)

625,000

02

63,639,528 (94.09%)

 

3,995,278 (5.91%)

67,634,806 (83.37%)

625,000

03

63,639,528 (93.23%)

4,620,278 (6.77%)

68,259,806 (84.14%)

 

0

 

The Company confirms that, conditional on Admission becoming effective, it has allotted and issued 4,000,000 new Ordinary Shares pursuant to the EIS/VCT Placing. It is expected that the EIS/VCT Placing Shares will be admitted to AIM with effect from 8.00am tomorrow, 2 August 2018.

 

Further details regarding the Placing and the Placing Shares can be found in the announcement issued by the Company on 13 July 2018 and in the Circular posted to Shareholders on that same day, which are available to view on the Company's website: investors.creomedical.com. Capitalised terms used, but not defined, in this announcement shall have the same meaning as set out in the Circular.

 

Following Admission of the EIS/VCT Placing Shares, the Company's issued ordinary share capital will consist of 85,123,065 Ordinary Shares; no shares are held in treasury. The above figure of 85,123,065 Ordinary Shares may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The Additional EIS/VCT Placing is conditional on receipt of the Additional VCT Advanced assurance by the Company. Whilst the Non EIS/VCT Placing is not conditional the receipt of the Additional VCT Advanced Assurance, the allotment and Admission of the Non EIS/VCT Shares cannot take place before the allotment of the Additional EIS/VCT Shares.

 

As the Additional VCT Advanced Assurance has not yet been obtained, the issue of the Additional EIS/VCT Shares and the Non EIS/VCT Shares has been delayed. Admission of the Additional EIS/VCT Shares and Non EIS/VCT Shares will occur on the third Business Day following receipt of Additional VCT Advanced Assurance.

 

In the event that the Additional VCT Advanced Assurance is not received before the Long Stop Date of 13 September 2018 (or at such time as HMRC has informed the Company that such approval will not be obtained), then the Additional EIS/VCT Placing will not complete, but the Non EIS/VCT Placing will complete, the Non EIS/VCT Shares will be issued and Admission of the Non EIS/VCT Shares will take place at latest on the Long Stop Date.

 

Contacts

 

Creo Medical:

+44 (0)129 160 6005

Richard Rees

Cenkos:

+44 (0)207 397 8900

Camilla Hume / Mark Connelly (NOMAD)

Michael Johnson / Russell Kerr (Sales)

FTI Consulting:

+44 (0)203 727 1000

Brett Pollard / Mo Noonan

creo@fticonsulting.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMSSEFEFFASEEA
Date   Source Headline
25th Mar 20107:00 amRNSDirector/PDMR Shareholding
23rd Mar 20107:00 amRNSResult of Tender Offer
8th Mar 20107:00 amRNSCircular re Tender Offer
8th Mar 20107:00 amRNSPreliminary Results
19th Feb 20107:00 amRNSBlocklisting Interim Review
5th Feb 20107:00 amRNSTrading Update
18th Jan 20107:00 amRNSDisposal
10th Dec 20097:00 amRNSNew Loan Facility
30th Nov 20094:13 pmRNSDirector Disclosure
25th Nov 20095:34 pmRNSDirector Declaration
25th Nov 200912:00 pmRNSProposed issue of zero dividend preference shares
20th Nov 20099:49 amRNSDisposal
12th Nov 20099:48 amRNSDisposal
5th Nov 200910:12 amRNSDisposal
7th Sep 200910:39 amRNSPublication of Financial Accounts
25th Aug 20097:00 amRNSInterim Results
18th Aug 20097:00 amRNSDirectorate Change
4th Aug 20097:00 amRNSTreasury Building Refinance
6th Jul 20097:00 amRNSBlocklisting Interim Review
1st Jul 20097:00 amRNSDirector/PDMR Shareholding
29th Jun 20097:00 amRNSDirectorate Change
24th Jun 20097:00 amRNSDisposal of Minority Stake
11th Jun 20097:00 amRNSAmendments to Investment Management Agreement
10th Jun 200911:18 amRNSResult of AGM
23rd Apr 200910:34 amRNSAnnual Report and Accounts
20th Apr 200912:52 pmRNSHolding(s) in Company
9th Apr 20099:05 amRNSIssue of Equity
3rd Apr 20091:24 pmRNSNotifiable interest in securities
1st Apr 20093:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20093:24 pmRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSFinal Results
22nd Jan 20095:00 pmRNSDirector/PDMR Shareholding
20th Jan 200911:00 amRNSSignificant shareholder notification
16th Jan 20099:31 amRNSTransaction in Own Shares
15th Jan 20093:57 pmRNSNotifiable interest in securities
15th Jan 20098:46 amRNSTransaction in Own Shares
13th Jan 20099:00 amRNSRe Call Option Agreement
5th Jan 20093:40 pmRNSSignificant shareholder notification
5th Jan 200910:39 amRNSSignificant shareholder notification
2nd Jan 20099:34 amRNSBlock Listing 6 monthly review
31st Dec 20089:57 amRNSTransaction in own securities
19th Dec 20084:33 pmRNSTransaction in Own Shares
9th Dec 20087:00 amRNSAppointment of Nomad and Joint Broker
8th Dec 20084:14 pmRNSGrant of Options
3rd Dec 200811:25 amRNSResult of EGM
26th Nov 20087:00 amRNSAppointment of Joint Broker
26th Nov 20087:00 amRNSRREEF Share Purchase
21st Nov 20089:24 amRNSCall Option Agreement
14th Nov 20087:00 amRNSGrant of Options
10th Nov 200811:52 amRNSNotice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.